000			01818 a2200517 4500
005			20250514002907.0
264		0	_c20011011
008			200110s 0 0 eng d
022			_a0264-410X
024	7		_a10.1016/s0264-410x(01)00132-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aNoormohammadi, A H
245	0	0	_aParadoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigen. _h[electronic resource]
260			_bVaccine _cJul 2001
300			_a4043-52 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAmino Acid Sequence
650	0	4	_aAnimals
650	0	4	_aAntigens, Protozoan _xadministration & dosage
650	0	4	_aAntigens, Surface _xadministration & dosage
650	0	4	_aBase Sequence
650	0	4	_aCOS Cells
650	0	4	_aDNA Primers _xgenetics
650	0	4	_aFemale
650	0	4	_aInterferon-gamma _xbiosynthesis
650	0	4	_aInterleukin-12 _xadministration & dosage
650	0	4	_aLeishmania major _xgenetics
650	0	4	_aLeishmaniasis, Cutaneous _ximmunology
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C3H
650	0	4	_aMolecular Sequence Data
650	0	4	_aPlasmids _xgenetics
650	0	4	_aProtozoan Proteins
650	0	4	_aProtozoan Vaccines _xadministration & dosage
650	0	4	_aTh1 Cells _ximmunology
650	0	4	_aTh2 Cells _ximmunology
650	0	4	_aVaccines, DNA _xadministration & dosage
700	1		_aHochrein, H
700	1		_aCurtis, J M
700	1		_aBaldwin, T M
700	1		_aHandman, E
773	0		_tVaccine _gvol. 19 _gno. 28-29 _gp. 4043-52
856	4	0	_uhttps://doi.org/10.1016/s0264-410x(01)00132-3 _zAvailable from publisher's website
999			_c11356719 _d11356719